Quick Answer
Ocugen, Inc. reported Long Term Debt of $27.54 million for the year ending 2025.
- Ocugen, Inc. showed an increase of +0.7% in Long Term Debt from 2024 to 2025.
- This data is from Ocugen, Inc.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2018 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2019: $1.06 million | Q1 2020: $1.58 million | Q2 2020: $2.02 million | Q3 2020: $1.94 million | Q1 2021: $1.70 million | Q2 2021: $1.67 million | Q3 2021: $1.69 million | Q1 2024: $1.53 million | Q2 2024: $1.55 million | Q3 2024: $1.57 million | Q1 2025: $27.67 million | Q2 2025: $28.03 million | Q3 2025: $28.40 million.
- Over the full 14 years of available data (2018 to 2025), Ocugen, Inc.'s Long Term Debt has grown by 2,608.9%.
- Historical annual values: Fiscal year 2025: $27.54 million | Fiscal year 2024: $27.35 million | Fiscal year 2023: $2.80 million | Fiscal year 2023: $1.50 million | Fiscal year 2023: $1.47 million | Fiscal year 2023: $1.06 million | Fiscal year 2022: $2.29 million | Fiscal year 2022: $2.27 million | Fiscal year 2022: $1.75 million | Fiscal year 2022: $1.73 million | Fiscal year 2021: $1.71 million | Fiscal year 2020: $1.82 million | Fiscal year 2019: $1.07 million | Fiscal year 2018: $1.02 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: